Literature DB >> 28352031

Vasculitis and vasculopathy in Lupus Nephritis: Clinical variability, outcome, and new insight into treatment.

A Kaul1, V Agrawal2, D Bhaduaria1, Vikas Agrawal3, Narayan Prasad1, Amit Gupta1, R K Sharma1.   

Abstract

More than 50% of patients with systemic lupus erythematosus (SLE) have renal involvement at presentation or during their illness. Lupus nephritis (LN) encompasses several patterns of renal disease, including glomerular, tubulointerstitial, and vascular pathologies. The presence and significance of renal vascular lesions (VLs) are often overlooked. VLs in LN are not rare with an incidence of 10%-40% on renal biopsies from various studies and their presence is often labeled as poor prognostic markers. The current treatment protocol for LN is mainly based on the glomerular pathology, and no guidelines/consensus exists for treatment of LN with VLs. We describe the clinical presentation, course, response to therapy, and outcomes in five patients with SLE with histological evidence of renal VLs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28352031     DOI: 10.4103/1319-2442.202777

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  2 in total

1.  A case of lupus vasculopathy presenting favorable renal outcome.

Authors:  Yuri Ishizaki; Ayako Aizawa; Shoko Ochiai; Akihiro Minakawa; Shunichi Miyauchi; Kunihiko Umekita; Yuji Sato; Yayoi Ogawa; Yoshio Kushida; Akihiko Okayama; Noriko Uesugi; Shouichi Fujimoto
Journal:  CEN Case Rep       Date:  2019-12-20

2.  Value of monitoring urine ammonia at time of biopsy in patients with lupus nephritis.

Authors:  Huanhuan Zhu; Huiting Wan; Suyan Duan; Chengning Zhang; Qing Li; Simeng Liu; Lin Wu; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  BMC Nephrol       Date:  2020-10-20       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.